Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $2.353B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 245,000 | $109M | 4.6% | $351.77 | +13.2% | COM NEW | 46120E602 |
| BSX | BOSTON SCIENTIFIC CORP | 1,170,100 | $90.11M | 3.8% | $49.10 | +49.1% | COM | 101137107 |
| NTRA | NATERA INC | 766,500 | $83M | 3.5% | $55.01 | +84.6% | COM | 632307104 |
| ARVN | ARVINAS INC | 2,987,845 | $79.54M | 3.4% | $47.79 | -33.3% | COM | 04335A105 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 1,120,000 | $75.64M | 3.2% | $72.97 | -4.3% | COM | 00404A109 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,917,231 | $75.5M | 3.2% | $18.09 | +32.9% | COM | 252828108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,335,000 | $68.47M | 2.9% | $18.49 | +13.2% | COM | 87164F105 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 491,000 | $67.6M | 2.9% | $96.63 | +41.9% | COM | 64125C109 |
| AVTR | AVANTOR INC | 3,086,000 | $65.42M | 2.8% | $21.56 | +11.7% | COM | 05352A100 |
| CI | THE CIGNA GROUP | 184,500 | $60.99M | 2.6% | $317.75 | +5.2% | COM | 125523100 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 544,500 | $58.11M | 2.5% | $142.84 | -23.0% | SHS USD | G50871105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 222,000 | $53.95M | 2.3% | $166.82 | -5.4% | COM | 02043Q107 |
| REGN | REGENERON PHARMACEUTICALS | 48,000 | $50.45M | 2.1% | $775.58 | +24.3% | COM | 75886F107 |
| ILMN | ILLUMINA INC | 478,000 | $49.89M | 2.1% | $133.40 | -15.9% | COM | 452327109 |
| THC | TENET HEALTHCARE CORP | 372,000 | $49.49M | 2.1% | $51.02 | +135.9% | COM NEW | 88033G407 |
| ABBV | ABBVIE INC | 277,800 | $47.65M | 2.0% | $139.64 | +12.5% | COM | 00287Y109 |
| TMO | THERMO FISHER SCIENTIFIC INC | 80,000 | $44.24M | 1.9% | $529.04 | +7.7% | COM | 883556102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,075,000 | $42.22M | 1.8% | $43.81 | — | SPONSORED ADS | 86366E106 |
| — | BLUEPRINT MEDICINES CORP | 383,000 | $41.28M | 1.8% | $57.39 | — | COM | 09627Y109 |
| CGON | CG ONCOLOGY INC | 1,296,225 | $40.92M | 1.7% | $40.84 | -15.1% | COM | 156944100 |
| MRK | MERCK & CO INC | 325,000 | $40.23M | 1.7% | $115.77 | +5.1% | COM | 58933Y105 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 960,000 | $39.46M | 1.7% | $51.17 | -16.6% | COM | 90400D108 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,117,000 | $39.22M | 1.7% | $24.09 | +64.4% | COM | 45166A102 |
| DHR | DANAHER CORPORATION | 150,000 | $37.48M | 1.6% | $217.74 | +14.9% | COM | 235851102 |
| JANX | JANUX THERAPEUTICS INC | 840,219 | $35.2M | 1.5% | $35.44 | +32.5% | COM | 47103J105 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 110,000 | $35.04M | 1.5% | $230.49 | +14.8% | COM | 91307C102 |
| INCY | INCYTE CORP | 529,000 | $32.07M | 1.4% | $56.64 | 0.0% | COM | 45337C102 |
| SGRY | SURGERY PARTNERS INC | 1,306,477 | $31.08M | 1.3% | $28.11 | -8.7% | COM | 86881A100 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 3,037,668 | $30.29M | 1.3% | $14.46 | 0.0% | COM NEW | 46489V302 |
| AXSM | AXSOME THERAPEUTICS INC | 376,000 | $30.27M | 1.3% | $55.95 | +32.3% | COM | 05464T104 |
| XENE | XENON PHARMACEUTICALS INC | 754,000 | $29.4M | 1.2% | $37.24 | +7.3% | COM | 98420N105 |
| DXCM | DEXCOM INC | 259,000 | $29.37M | 1.2% | $125.93 | +0.4% | COM | 252131107 |
| RVMD | REVOLUTION MEDICINES INC | 755,000 | $29.3M | 1.2% | $30.15 | +24.0% | COM | 76155X100 |
| INSM | INSMED INC | 430,000 | $28.81M | 1.2% | $38.78 | 0.0% | COM PAR $.01 | 457669307 |
| — | INTRA-CELLULAR THERAPIES INC | 400,000 | $27.4M | 1.2% | $52.09 | — | COM | 46116X101 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,559,826 | $27.2M | 1.2% | $21.29 | 0.0% | COM | 230031106 |
| GKOS | GLAUKOS CORP | 224,000 | $26.51M | 1.1% | $89.35 | +18.8% | COM | 377322102 |
| NGNE | NEUROGENE INC | 727,537 | $26.48M | 1.1% | $21.87 | +61.3% | COM | 64135M105 |
| ARGX | ARGENX SE | 60,500 | $26.02M | 1.1% | $430.04 | — | SPONSORED ADR | 04016X101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 731,104 | $25M | 1.1% | $27.38 | -4.3% | COM | 604749101 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 531,000 | $24.13M | 1.0% | $46.24 | +9.7% | COM | G31249108 |
| IMVT | IMMUNOVANT INC | 908,000 | $23.97M | 1.0% | $27.93 | +1.8% | COM | 45258J102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,100,000 | $23.68M | 1.0% | $19.03 | +20.7% | COM | 77313F106 |
| LNTH | LANTHEUS HLDGS INC | 290,000 | $23.28M | 1.0% | $75.93 | -3.4% | COM | 516544103 |
| PCVX | VAXCYTE INC | 284,000 | $21.44M | 0.9% | $39.49 | +72.4% | COM | 92243G108 |
| APGE | APOGEE THERAPEUTICS INC | 487,000 | $19.16M | 0.8% | $44.68 | +8.6% | COM | 03770N101 |
| JSPR | JASPER THERAPEUTICS INC | 782,000 | $17.75M | 0.8% | $17.94 | +33.7% | COM NEW | 471871202 |
| NMRA | NEUMORA THERAPEUTICS INC. | 1,800,000 | $17.69M | 0.8% | $12.81 | -19.3% | COM | 640979100 |
| LEGN | LEGEND BIOTECH CORP | 398,000 | $17.63M | 0.7% | $52.73 | — | SPONSORED ADS | 52490G102 |
| GILD | GILEAD SCIENCES INC | 255,000 | $17.5M | 0.7% | $63.13 | 0.0% | COM | 375558103 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,620,000 | $16.69M | 0.7% | $21.46 | -52.0% | COM | 71722W107 |
| AZN | ASTRAZENECA PLC | 205,000 | $15.99M | 0.7% | $70.00 | — | SPONSORED ADR | 046353108 |
| KROS | KEROS THERAPEUTICS INC | 343,200 | $15.68M | 0.7% | $57.13 | -5.9% | COM | 492327101 |
| BHVN | BIOHAVEN LTD | 450,000 | $15.62M | 0.7% | $35.30 | +12.0% | COM | G1110E107 |
| SNY | SANOFI | 315,000 | $15.28M | 0.6% | $48.52 | — | SPONSORED ADR | 80105N105 |
| RGNX | REGENXBIO INC | 1,300,064 | $15.21M | 0.6% | $17.79 | -12.5% | COM | 75901B107 |
| CNTX | CONTEXT THERAPEUTICS INC | 7,419,355 | $14.88M | 0.6% | $1.72 | 0.0% | COM | 21077P108 |
| EXAS | EXACT SCIENCES CORP | 338,500 | $14.3M | 0.6% | $55.02 | 0.0% | COM | 30063P105 |
| PRVA | PRIVIA HEALTH GROUP INC | 764,200 | $13.28M | 0.6% | $26.12 | -32.2% | COM | 74276R102 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 559,300 | $10.74M | 0.5% | $20.26 | -1.0% | ORDINARY SHARES | N62509109 |
| IMNM | IMMUNOME INC | 873,891 | $10.57M | 0.4% | $8.31 | +88.1% | COM | 45257U108 |
| IMUX | IMMUNIC INC | 8,902,972 | $9.882M | 0.4% | $1.30 | -4.4% | COM | 4525EP101 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 215,600 | $9.756M | 0.4% | $42.06 | 0.0% | COM NEW | 21833P301 |
| — | CYBIN INC | 34,884,000 | $9.454M | 0.4% | $0.41 | — | COM | 23256X100 |
| SYRS | SYROS PHARMACEUTICALS INC | 1,673,538 | $8.635M | 0.4% | $5.92 | -11.2% | COM NEW | 87184Q206 |
| COGT | COGENT BIOSCIENCES INC | 1,000,706 | $8.436M | 0.4% | $6.96 | +9.0% | COM | 19240Q201 |
| IMCR | IMMUNOCORE HLDGS PLC | 200,000 | $6.778M | 0.3% | $41.38 | — | ADS | 45258D105 |
| TYRA | TYRA BIOSCIENCES INC | 373,000 | $5.964M | 0.3% | $17.21 | 0.0% | COM | 90240B106 |
| PATH | UIPATH INC | 362,000 | $4.59M | 0.2% | $17.29 | 0.0% | CL A | 90364P105 |
| SYRE | SPYRE THERAPEUTICS INC | 195,000 | $4.584M | 0.2% | $33.73 | 0.0% | COM NEW | 00773J202 |
| IMTX | IMMATICS N.V | 393,100 | $4.568M | 0.2% | $11.27 | 0.0% | SHS | N44445109 |
| IONS | IONIS PHARMACEUTICALS INC | 93,000 | $4.432M | 0.2% | $47.67 | -14.0% | COM | 462222100 |
| — | ARCA BIOPHARMA INC | 1,000,000 | $3.83M | 0.2% | $3.83 | — | COM | 00211Y506 |
| EDIT | EDITAS MEDICINE INC | 816,000 | $3.811M | 0.2% | $5.64 | 0.0% | COM | 28106W103 |
| NTLA | INTELLIA THERAPEUTICS INC | 170,000 | $3.805M | 0.2% | $23.81 | 0.0% | COM | 45826J105 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 117,000 | $3.767M | 0.2% | $25.87 | +34.0% | COM | 19459J104 |
| PRME | PRIME MEDICINE INC | 694,000 | $3.567M | 0.2% | $7.58 | -20.1% | COM | 74168J101 |
| ACIU | AC IMMUNE SA | 825,000 | $3.292M | 0.1% | $2.61 | +27.0% | SHS | H00263105 |
| — | KEZAR LIFE SCIENCES INC | 5,026,000 | $3.016M | 0.1% | $12.16 | — | COM | 49372L100 |
| SCYX | SCYNEXIS INC | 1,448,728 | $2.897M | 0.1% | $2.82 | -31.6% | COM NEW | 811292200 |
| — | KARYOPHARM THERAPEUTICS INC | 2,018,500 | $1.751M | 0.1% | $3.40 | — | COM | 48576U106 |
| WVE | WAVE LIFE SCIENCES LTD | 350,000 | $1.746M | 0.1% | $5.70 | 0.0% | SHS | Y95308105 |
| HYPR | HYPERFINE INC | 1,188,178 | $1.01M | 0.0% | $9.78 | -91.0% | COM CL A | 44916K106 |
| — | CAREMAX INC | 21,200 | $59,148 | 0.0% | $4.82 | — | CL A NEW | 14171W202 |
| — | NUVATION BIO INC | 12,136 | $1,942 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |